معرفی
Mark W Grinstaff is a Professor at Boston University, leading the Grinstaff Group, which focuses on interdisciplinary biomaterials and biomedical engineering research. His work addresses healthcare challenges through innovations in diagnostics, devices, and therapeutics. He holds a B.A. from Occidental College (1987) and a Ph.D. from the University of Illinois at Urbana-Champaign (1992).
Research interests include designing biodendrimers for tissue engineering, interfacial biomaterials, and conducting polymer-based sensors. Key areas span cartilage repair, drug delivery systems (e.g., anticancer, DNA), and biodegradable scaffolds. He explores nanoparticle-based imaging agents for osteoarthritis diagnosis and biomechanical assessments using computed tomography.
Recent publications highlight advancements in machine learning-driven osteoarthritis classification, dual-contrast agents for cartilage imaging, and synthetic biolubricants for equine models. His group emphasizes translational research, with a focus on nanotechnology, regenerative medicine, and therapeutic delivery platforms.
Grinstaff’s work is supported by grants and collaborations, though specific grants are not detailed in the text. He advises students through the Grinstaff Group, though no student names are listed here. His lab develops novel materials and devices, including polymeric adhesives and biosensors, with applications in orthopedics, oncology, and infectious diseases.
